ONLINE GOLD AND SILVER TREND DAILY ALERTS: 23RD NOVEMBER 2010

By Editorial Team -

XAU/USD (Gold): Bought (Long) at USD 1364.55/ounce (23 Nov 2010) Close position if price goes below USD 1337.00/oz  (support at 50 DMA (daily moving average))
XAG/USD (Silver): Bought (Long) at USD 26.55/ounce (19 Nov 2010) Maintain long position. Close position if price goes below USD 25.95/oz (support at 20 DMA (daily moving average))






Comments

Post a Comment

Pages

Popular posts from this blog

Innovations in Wearable Technology (2026): The Future of AI-Driven Health, Performance, and Human Augmentation

By -
Image
Wearable technology in 2026 is no longer just about counting steps or tracking calories. It has evolved into a continuous, AI-powered health intelligence system —capable of predicting disease, optimizing performance, and even augmenting human capabilities. A large study, published in  The Lancet (2026)  and drawing on wearable-device data from more than 135,000 adults, found that remarkably small increases in daily movement — and modest reductions in sitting — were associated with meaningful drops in mortality (death-rate). We are entering a new phase:  Wearables → Health Intelligence Platforms This article breaks down the most important innovations in wearable technology in 2026, and what they mean for consumers, healthcare, and investors. 1. Continuous Health Monitoring (24/7 Biometrics) Modern wearables now go far beyond basic metrics. Key innovations: Continuous heart rate variability (HRV) tracking Blood oxygen (SpO2) monitoring Skin temperature and stress detection ...
Read more

AI Wearable Technology Innovations (2026): Health, Fitness & Beyond

By -
Image
Artificial intelligence (AI) is redefining what wearable technology can do. In 2026, wearables are no longer passive tracking devices — they are becoming intelligent, predictive, and deeply personalized health and lifestyle companions. Source:  Grand View Research Recent advances in intelligent wearable systems: from multiscale biomechanical features towards human motion intent prediction (source:  Nature 2026 ) From smart rings and AI fitness coaches to augmented reality glasses and skin-integrated sensors, AI-powered wearables are transforming healthcare, wellness, productivity, and human-machine interaction. 1. AI-Driven Health Monitoring and Early Detection Advanced AI algorithms are dramatically improving the accuracy of wearable health sensors. Machine learning models filter noise, personalize baselines, and detect anomalies related to heart rhythm, blood oxygen, stress, and sleep. Modern wearables now approach clinical-grade monitoring, enabling early detection of c...
Read more

Tokenization of Real-World Assets (RWA) in 2026: The $30 Trillion Opportunity Reshaping Finance

By -
Image
Tokenization of real-world assets (RWAs) has moved beyond hype and into mainstream institutional adoption . In 2026, financial giants like BlackRock, JPMorgan Chase, and Goldman Sachs are actively launching tokenized products—ranging from money market funds to private credit and Treasuries . The core concept is simple but powerful: Convert real-world assets into blockchain-based tokens Enable fractional ownership and global access Unlock liquidity in traditionally illiquid markets 👉 The result: a potential $10–30 trillion market by 2030. What Is Real-World Asset (RWA) Tokenization? RWA tokenization is the process of representing ownership of physical or financial assets as digital tokens on a blockchain. These tokens can represent: Real estate Bonds and Treasuries Private equity Commodities like gold Art and collectibles Unlike traditional systems, tokenization enables: Fractional ownership (own a small piece of expensive assets) Near-instant settlement 24/7 trading across borders Why...
Read more

Top 10 Food Companies by Revenue — 2026 Update

By -
Image
The ten largest food and beverage companies in the world remain Nestle, Ahold Delhaize, PepsiCo., Archer Daniels Midland, Sysco, JBS, Performance Food Group, Anheuser-Busch InBev, Unilever, and Tyson Foods. The global food and beverage industry remains one of the largest and most resilient sectors of the world economy, generating trillions of dollars in annual revenue . While consumer preferences, inflation, and supply-chain realignments continue to reshape the market, a relatively small group of multinational corporations still dominate global food sales. This January 2026 update revises our original 2025 rankings using the latest available full-year 2024 results, 2025 trailing-twelve-month (TTM) data, and confirmed late-2025 corporate developments , including major mergers, recalls, and strategic restructurings.  Top 10 Food Companies by Revenue This ranking reflects the largest companies primarily by annual revenue, emphasizing food production, processing, distri...
Read more

Largest Pharma Companies in the World (2025–2026 Revenue Rankings)

By -
Image
Table of Contents: Largest Pharma Companies by Revenue (Global Ranking) Top 10 Pharmaceutical Companies by Market Cap in 2025 Top 10 Most Anticipated Drug Launches of 2025 Top 10 Drugs Losing US Exclusivity in 2025 The largest pharma companies in the world play a central role in global healthcare, developing blockbuster drugs for cancer, cardiovascular disease, immunology, vaccines, and metabolic disorders. In 2025, the biggest pharmaceutical companies by revenue continued to dominate through scale, research spending, and global distribution—despite growing pressure from patent expirations, biosimilars, and pricing reforms. Medical stocks are releasing earnings reports in droves. Eli Lilly and Co (LLY.US) targets $80 billion in 2026 revenue with standout performance; Novo-Nordisk A/S (NVO.US) beats Q4 expectations but lowers 2026 guidance due to pricing pressures. The largest pharma companies are defined not only by revenue, but by global scale, research investment, and thera...
Read more

9 Best Crypto Scam Recovery Companies (2026 Guide): What Actually Works

By -
Image
Introduction Crypto scams have become more sophisticated in 2026, driven by AI-powered phishing, fake recovery agents, deepfake influencers, and cross-chain laundering. While blockchain transparency makes tracing possible, crypto transactions remain irreversible , and recovery is never guaranteed. This updated 2026 guide explains: Which crypto scam recovery services are legitimate What recovery companies can and cannot do How to avoid recovery scams , now more common than ever When law enforcement and exchanges matter more than private firms Critical warning: Any service promising guaranteed recovery in 2026 is likely to be a scam as well. What Legitimate Crypto Recovery Services Can Do (2026 Reality Check) They CAN: Trace stolen funds on public blockchains Identify laundering paths (bridges, mixers, exchanges) Produce forensic reports for exchanges, lawyers, or police Assist with exchange...
Read more

AI Demand Drives Ongoing SSD & Memory Shortages: Prices Surging Further into 2026 and Beyond

By -
Image
As we enter 2026, the memory and storage crunch predicted in late 2025 has materialized with even greater intensity. AI data centers continue to dominate global production of DRAM and NAND flash, pushing prices sharply higher and extending lead times across consumer, PC, and enterprise segments. Nearly every analyst firm and memory maker is now warning of looming NAND and DRAM shortages that will send SSD and memory prices skyrocketing over the coming months and years, with some even predicting a shortage that will last a decade. For the better part of two years, storage upgrades have been a rare bright spot for PC builders. SSD prices cratered to all-time lows in 2023 , with high-performance NVMe drives selling for little more than the cost of a modest mechanical hard disk. DRAM followed a similar trajectory, dropping to price points not seen in nearly a decade. In 2024, the pendulum swung firmly in the other direction, with prices for both NAND flash and DRAM sta...
Read more

Top AI Stocks & ETFs for 2026: Powering the Next Boom

By -
Image
Artificial intelligence is no longer a theme—it is becoming the core infrastructure of global economic growth . From semiconductor design to cloud computing, automation, defense systems, and drug discovery, AI is now embedded across every major industry. The global generative AI market size is calculated at USD 25.8 billion in 2024 and is predicted to reach around USD 11.08 billion by 2034, expanding at a CAGR of 45.6% from 2024 to 2034. ( statifacts )   With hyperscalers (Microsoft, Amazon, Google, Meta) projected to spend over $500 billion on AI capex in 2026 alone (up from prior estimates), demand for data centers, chips, networking, cooling, and power is exploding. This isn't just hype—it's a multi-year buildout rivaling the internet era, with supply shortages persisting into 2026. Update:  Best ETFs to Buy During the 2026 Energy Crisis  (Protect Your Portfolio Now) Our "One-Day Decision" guide focuses on act...
Read more

Top 10 Drugs by Worldwide Sales in 2025

By -
Image
The pharmaceutical market in 2025 continues to be led by innovative therapies addressing cancer, metabolic diseases, autoimmune conditions, and chronic illnesses. Below is an updated overview of the top 10 drugs by projected global sales in 2025. Summary 1. Keytruda (Merck): 31B 2. Ozempic (Novo Nordisk): 21 B 3. Mounjaro (ELi Lilly): 19 B 4. Dupixent (Sanofi and Regeneron): 17 B 5. Wegovy (Novo Nordisk): 14 B 6. Biktarvy (Gilead Sciences): 13.4 B 7. Skyrizi (Abbvie): 13 B 8. Eliquis (Bristol-Myers Squibb): 13 B 9. Darzalex (Johnson & Johnson): 13 B 10. Humira (Abbvie): 12.5 B Highlights and Market Trends Keytruda (Pembrolizumab) remains the global leader in drug sales with projected revenues exceeding $31 billion in 2025. This cancer immunotherapy has expanded to over 40 approved indications since its launch in 2014, including multiple cancer types, driving strong sales growth. Merck reported $21.6 billion in sales for the first three quarters of 2024, an 18% increase year-on-year...
Read more

Top Cancer Drug Companies (2026 Update): Leaders by Revenue, Pipeline, and Growth

By -
Image
Reviewed by: OneDayAdvisor Editorial Team Last Updated: April 2026 The global oncology market is entering a new phase in 2026—defined by  immunotherapy dominance, CAR-T expansion, and next-gen targeted therapies . While legacy giants still dominate revenue,  earnings reports from Q1 2026 show a clear shift toward innovation-driven growth and aggressive M&A activity . This updated ranking incorporates: Latest  Q1 2026 earnings data Oncology revenue trends Pipeline strength and strategic positioning Competitive threats (patent cliffs, biosimilars) Related:  Latest Breakthroughs in Cancer Treatment In This Article: Merck (MRK) Bristol Myers Squibb Johnson & Johnson AstraZeneca Roche Novartis Eli Lilly (LLY) AbbVie Astellas Celgene 1. Merck & Co. Merck (MRK) reported strong Q4 2025 results on Feb 3, 2026, with revenue of $16.4 billion (5% increase year-over-year) and adjusted EPS o...
Read more